CE Marking | Manufacturer | Commercial Name | ID | Method | Target | Format | Navigate |
---|---|---|---|---|---|---|---|
CE Marking: Yes | Manufacturer: Neomedica d.o.o. | Commercial: NAISSA SARS-COV-2 IgA | Device ID: 1134 | Method: Immunoassay | Target: Antibody, IgA | Format: Automated | Go to details |
CE Marking: Yes | Manufacturer: Neomedica d.o.o. | Commercial: NAISSA SARS-COV-2 IgG | Device ID: 1087 | Method: Immunoassay | Target: Antibody, IgG | Format: Automated | Go to details |
CE Marking: Yes | Manufacturer: Neomedica d.o.o. | Commercial: NAISSA SARS-COV-2 IgM | Device ID: 1133 | Method: Immunoassay | Target: Antibody, IgM | Format: Automated | Go to details |
CE Marking: Yes | Manufacturer: Neomedica d.o.o. | Commercial: NAISSA SARS-COV-2 S1/S2/RBD Neutralizing antibodies | Device ID: 2377 | Method: ELISA | Target: Antibody, IgG | Format: Automated | Go to details |
CE Marking: Yes | Manufacturer: Neomedica d.o.o. | Commercial: SARS-COV-2 Ag NeoMedica | Device ID: 2236 | Method: Immunochromatography | Target: Antigen | Format: Manual, Near POC / POC | Go to details |
CE Marking: Yes | Manufacturer: Neomedica d.o.o. | Commercial: SARS-COV-2 Ag NeoMedica (R2703Ag) | Device ID: 2234 | Method: Immunochromatography | Target: Antigen | Format: Manual, Near POC / POC | Go to details |
The database contains publicly available In Vitro Diagnostic Medical Devices for COVID-19 and it is being updated periodically. Please note that additional performance (as retrieved from manufacturers web pages) is provided only for devices commercially available with CE-IVD mark. Acknowledgements